| Title | Immunotherapy |
| Abbreviation | Immunotherapy |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q2); Immunology (Q3); Immunology and Allergy (Q3) |
| h-index | 65 |
| Overall Rank/Ranking | 7611 |
| SCImago Journal Rank (SJR) | 0.69 |
| Impact Score | 2.46 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 1750743X, 17507448 |
| Best Quartile | Q2 |
| Coverage History | 2009-2023 |
Immunotherapy is a journal covering the technologies/fields/categories related to Oncology (Q2); Immunology (Q3); Immunology and Allergy (Q3). It is published by Taylor and Francis Ltd.. The overall rank of Immunotherapy is 7611. According to SCImago Journal Rank (SJR), this journal is ranked 0.69. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 65. The best quartile for this journal is Q2.
The ISSN of Immunotherapy journal is 1750743X, 17507448. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Immunotherapy is cited by a total of 1015 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Immunotherapy is 2.46, which is computed in 2024 as per its definition. Immunotherapy IF is decreased by a factor of 0.15 and approximate percentage change is -5.75% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Immunotherapy is 2.46. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.46 |
| 2022 | 2.61 |
| 2021 | 3.37 |
| 2020 | 3.11 |
| 2019 | 2.60 |
| 2018 | 2.64 |
| 2017 | 2.77 |
| 2016 | 2.42 |
| 2015 | 1.87 |
| 2014 | 1.72 |
Immunotherapy has an h-index of 65. It means 65 articles of this journal have more than 65 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Immunotherapy is 1750743X, 17507448. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Immunotherapy is 7611. According to SCImago Journal Rank (SJR), this journal is ranked 0.69. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.69 |
| 2022 | 0.798 |
| 2021 | 0.821 |
| 2020 | 1.127 |
| 2019 | 0.963 |
| 2018 | 1.062 |
| 2017 | 0.986 |
| 2016 | 0.829 |
| 2015 | 0.670 |
| 2014 | 0.769 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 7611 |
| 2022 | 5999 |
| 2021 | 5519 |
| 2020 | 3663 |
| 2019 | 4578 |
| 2018 | 3980 |
| 2017 | 4442 |
| 2016 | 5585 |
| 2015 | 7082 |
| 2014 | 5982 |
Immunotherapy is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2009-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Immunotherapy is Immunotherapy. This abbreviation ('Immunotherapy') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q2); Immunology (Q3); Immunology and Allergy (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Immunotherapy latest impact IF is 2.46. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.37 (2021) and 1.72 (2014), respectively, in the last 10 years. Moreover, its average IS is 2.56 in the previous 10 years.
The Immunotherapy has an SJR (SCImago Journal Rank) of 0.69, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.127 in 2020 and the lowest being 0.670 in 2015. Furthermore, the average SJR of the Immunotherapy over the previous 10-year period stands at 2.56.
The latest h-index of the Immunotherapy is 65.
The Immunotherapy is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The Immunotherapy is currently ranked 7611 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3663 in 2020 and its lowest position of 7611 in 2023.
The standard ISO4 abbreviation for the Immunotherapy is Immunotherapy.
Immunotherapy is classified as a journal that the Taylor and Francis Ltd. publishes.
The Immunotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Immunotherapy is assigned the following International Standard Serial Numbers (ISSN): 1750743X, 17507448.
The best quartile for the Immunotherapy is Q2 (2023).
The Immunotherapy coverage history can be summarized as follows: 2009-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Geriatric Physical Therapy | journal | 9578 | Lippincott Williams and Wilkins Ltd. | 47 | 1.23 |
| Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 678 | Association for Computing Machinery (ACM) | 106 | 7.58 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Journal des Professionnels de l'Enfance | journal | 28748 | TPMA | 2 | 0.00 |
| Genes and Nutrition | journal | 5793 | BioMed Central Ltd | 65 | 3.42 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| European Journal of Cancer, Supplement | journal | 6710 | Elsevier Ltd | 29 | 0.33 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.46 |
| 2022 | 2.61 |
| 2021 | 3.37 |
| 2020 | 3.11 |
| 2019 | 2.60 |
| 2018 | 2.64 |
| 2017 | 2.77 |
| 2016 | 2.42 |
| 2015 | 1.87 |
| 2014 | 1.72 |
